APRE · Aprea Therapeutics, Inc. · Investor Relations
Market Cap
$7.12M
Shares
12.59M
Volume · Oct 21
81.57K
Avg daily vol (3M)
289.2K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-30 15:00 UTC | Aprea Therapeutics, Inc. Pre-ESMO Virtual Panel: The State of WEE1 Inhibition in Precision Oncology | Webcast |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2025-09-09 | H.C. Wainwright Global Investment Conference | Conference |
| 2024-10-01 | Lytham Partners Fall 2024 Investor Conference | Conference |
| 2024-09-19 | Life Sciences Investor Forum | Webcast |
| 2024-09-10 | H.C. Wainwright 26th Annual Global Investment Conference | Conference |
| 2024-06-24 | -- Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor | Event |
| 2023-10-31 | Aprea Therapeutics KOL Event | Event |
| 2023-09-11 | HC Wainwright 25th Annual Global Investment Conference | Conference |
| 2023-06-21 | Maxim Virtual Healthcare Conference | Conference |
| 2023-03-14 | Oppenheimer 33rd Annual Healthcare Conference | Conference |
Source: https://ir.aprea.com/